Free Weekly Diagnostics Newsletter. Get the latest news on Market Launches, M&A and Partnership Deals, Clinical Milestones, and more sent straight to your Inbox. Join fellow diagnostics developers and manufacturers who subscribe to FierceDiagnostics for FREE!
For innovative pharmaceutical companies, opportunities for new pharmaceutical products exist within the products, patents, technologies and intellectual properties they already own or control. For these companies, and also for generic companies that are looking for alternative revenue sources to offset losses caused by the generic cliff, the 505(b)(2) pathway offers great potential. Learn more here.
FierceDiagnostics is the first place diagnostics developers and manufacturers turn to for industry news on market launches,M&A and partnership deals,clinical milestones, and more. Click here to get your free weekly email briefing today!